Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,023,300
+$18,719,990 QoQ
Shares Held
330,151
+6501.7% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#284
of 2,514 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority
Sole 97%
Shared 3%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Derivatives in BMY
reported options exposure · as of Jun 30, 2026CallValue
$48,089,652
CallShares
834,600
PutValue
$106,066,896
PutShares
1,840,800
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LMR Partners LLP holds $144,798,606 across 13 Drug Manufacturers - General names. BMY ranks #4 (13.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GSK |
GSK plc
|
980,479 | $51,396,709 | |
| 2 | NVS |
Novartis AG
|
153,726 | $24,091,938 | |
| 3 | ABBV |
AbbVie Inc.
|
79,736 | $20,064,766 | |
| 4 | BMY |
Bristol Myers Squibb Co
This page
|
330,151 | $19,023,300 | |
| 5 | PFE |
Pfizer Inc
|
260,990 | $6,284,639 | |
| 6 | MRK |
Merck & Co., Inc.
|
44,030 | $5,657,855 | |
| 7 | OGN |
Organon & Co.
|
396,842 | $5,373,240 | |
| 8 | LLY |
ELI LILLY & Co
|
3,390 | $4,066,066 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,023,300 | 330,151 | Shares | Other | 2026-08-14 | |
| 2026-06-30 | $48,089,652 | 834,600 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $106,066,896 | 1,840,800 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $303,310 | 5,001 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $67,582,295 | 1,114,300 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $22,112,990 | 364,600 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $26,937,636 | 499,400 | Put | Sole | 2026-02-17 | |
| 2025-12-31 | $270,401 | 5,013 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,537,800 | 278,000 | Call | Sole | 2025-11-14 | |
| 2025-09-30 | $3,598,438 | 79,788 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $27,637,280 | 612,800 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $2,545,950 | 55,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $12,146,496 | 262,400 | Put | Sole | 2025-08-14 | |
| 2025-03-31 | $3,049,500 | 50,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $7,318,800 | 120,000 | Put | Sole | 2025-05-15 | |
| 2025-03-31 | $2,585,366 | 42,390 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $7,475,365 | 132,167 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,587,000 | 50,000 | Put | Sole | 2024-11-07 | |
| 2024-09-30 | $13,450,433 | 259,962 | Shares | Sole | 2024-11-07 | |
| 2024-03-31 | $1,626,900 | 30,000 | Put | Sole | 2024-05-15 | |
| 2021-09-30 | $370,700 | 6,265 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $855,979 | 13,559 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,107,421 | 17,853 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,166,611 | 19,350 | Shares | Sole | 2020-11-16 | |
| 2020-03-31 | $2,921,500 | 52,413 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||